Dr. Zoë Harcombe on Sugar, Carbs, and the Dangers of Sweeteners & GLP-1 Agonists

The Truth About Sugar and Carbohydrates

• 💡 The body does not distinguish between sugar in fruit and refined sugar; it processes both as glucose and fructose.
• 🎯 While glucose enters the bloodstream, fructose is processed by the liver, potentially leading to non-alcoholic fatty liver disease.
• ⚠️ Governments recommending high carbohydrate intake while advising to eat less sugar is misunderstood and ignorant nutrition advice.
• 🔑 All carbohydrates ultimately break down into sugar, making the distinction between "carbohydrates" and "sugar" misleading.

The Problem with "Real Food" Sweeteners

• 🚫 Sweeteners like maple syrup, honey, and date sugar are not considered real food because they are processed and not found naturally.
• 📈 Using these sweeteners can perpetuate a taste for sweet things, making it harder to reduce sugar cravings.
• 📉 It's often easier to avoid sweet foods entirely than to consume them in moderation, as they are designed to be addictive.
• 🍎 When artificial sweetness is removed from the diet, natural foods like cherry tomatoes and milk begin to taste noticeably sweet.

Concerns About Artificial Sweeteners and Sugar Alcohols

• 🧪 Artificial sweeteners, including stevia and monk fruit, are dismissed for being unnatural and not helping to curb a sweet tooth.
• ⚠️ Sugar alcohols (like sorbitol, mannitol) can have laxative effects, causing severe digestive distress as experienced at a conference demonstration.
• ❌ These sweeteners are not recommended; the advice is to stick to real food.

Worries Regarding GLP-1 Agonists

• 🔬 GLP-1 agonists are a concern due to their novelty and insufficient long-term safety data, despite their use for type 2 diabetes.
• 📉 Historically, many diet drugs have been withdrawn due to serious side effects (e.g., Reductil causing heart attacks), suggesting caution with new powerful drugs.
• ⚠️ There are already deaths associated with GLP-1 agonists, yet they remain on the market without thorough investigation.
• 💰 Conflicted researchers, funded by drug companies, promote these drugs for benefits beyond obesity, potentially creating a massive market that overshadows even statins.
• 🩺 The author expresses deep worry about the unforeseen consequences and widespread use of these powerful medications.